Functional mushrooms get discussed as though they are interchangeable. They are not. The compounds differ, the traditions behind them differ, and the research behind each one is at a different stage.
The thing they share: beta-glucans
Nearly all of these mushrooms are discussed in terms of beta-glucans, a polysaccharide found in fungal cell walls.
The reason immunologists find them interesting is specific and well established: humans have a receptor called Dectin-1 on certain immune cells that binds beta-glucans directly. This is not speculative. Dectin-1 is a recognised pattern-recognition receptor, and beta-glucan binding triggers a documented cascade including phagocytosis, cytokine production and initiation of adaptive immune responses.
In other words, your immune system carries dedicated machinery for recognising these compounds. That is an unusual thing to be able to say about a food.
Reishi (Ganoderma lucidum)
Reishi has the longest documented history of the four — it appears in East Asian medical texts going back centuries, traditionally taken for calm and recovery rather than stimulation.
It also has the strongest human trial of any mushroom in this guide. Tang and colleagues (2005), published in the Journal of Medicinal Food, ran a randomised, double-blind, placebo-controlled study in 132 patients with neurasthenia — a diagnosis characterised by fatigue, poor concentration and disturbed sleep. Participants took a Ganoderma lucidum polysaccharide extract or placebo for eight weeks.
The results favoured reishi on every measure taken. 51.6% of the reishi group showed significant clinical improvement, against 24.6% on placebo — a difference unlikely to be chance (p=0.002). Sense of fatigue fell further in the reishi group, insomnia severity scores improved, and the extract was well tolerated with no major adverse effects.
A trial of 132 people is not enormous, but it is four times the size of the most-cited Lion's Mane study, it is properly controlled, and it tested the thing reishi is traditionally taken for.
One point of context worth having, because it is often quoted out of shape: a Cochrane review examined Ganoderma lucidum as a cancer treatment and judged the evidence there very low quality. That is a real finding — but cancer treatment is an extraordinarily high bar, and it is a completely different question from whether reishi supports calm or recovery. Weak evidence for treating cancer says nothing either way about the traditional uses.
Chaga (Inonotus obliquus)
Chaga is the compositional outlier. It grows on living birch, drawing compounds from the tree, and the resulting profile is unlike anything else in the category: polyphenols, triterpenoids including inotodiol and lanosterol, superoxide dismutase, melanin, and betulinic acid derived from its birch host.
On the ORAC scale, which measures a food's capacity to neutralise free radicals, chaga ranks among the highest values recorded for any food. That is a measured compositional fact, not an inference — and it is the reason chaga is interesting at all.
Where to be straight: the human research is younger than the laboratory research. Reviews describe antioxidant, anti-inflammatory and antimicrobial activity, and most of that work is in vitro or in animal models rather than clinical trials. The composition is exceptional and well documented; the clinical picture is still being built.
This is also exactly why no supplement brand is allowed to tell you what these ingredients do. Claims about botanicals sit unassessed in GB law rather than rejected — a distinction we have written about in why no brand can legally tell you what its ingredients do.
Maitake and Shiitake
Both are culinary mushrooms first, which means humans have eaten them in quantity for a very long time — a reasonable baseline for safety.
Both are among the richest food sources of beta-glucans, which is what puts them in this conversation at all. Shiitake contains lentinan, a specific beta-glucan studied more thoroughly than most, and used as an adjunct in clinical settings in some countries — at injected pharmaceutical doses, which is not comparable to a supplement, but it does indicate the compound is taken seriously.
How to read a mushroom supplement label
- Fruiting body or mycelium? Different compound profiles. Mycelium grown on grain can carry substantial residual starch.
- What does "10:1" mean? Ten kilos of raw material produced one kilo of extract. Useful shorthand, but it says nothing about which compounds concentrated.
- Is beta-glucan content stated? The meaningful number, and frequently absent.
- Has it been tested? Mushrooms bioaccumulate from their substrate, heavy metals included. Ask for results.
Sources
- Tang W, Gao Y, Chen G, Gao H, Dai X, Ye J, Chan E, Huang M, Zhou S. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. Journal of Medicinal Food, 2005; 8(1):53–58. PubMed 15857210.
- Jin X, Ruiz Beguerie J, Sze DM, Chan GCF. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database of Systematic Reviews, 2016.
- Therapeutic properties of Inonotus obliquus (Chaga mushroom): a review. PubMed Central, PMC11132974.
- A brief overview of the medicinal and nutraceutical importance of Inonotus obliquus (chaga) mushrooms. Heliyon, 2024.
- β-Glucan size controls Dectin-1-mediated immune responses in human dendritic cells. Frontiers in Immunology, 2017; 8:791.
- Brown GD, Gordon S. Beta-glucans and dectin-1. PubMed 19076344.